Research indicates that many class I MHC phosphopeptides are uniquely expressed on diseased cells and are potential targets for the immunotherapy of hepatocellular cancer, breast cancer (22), melanoma (23), colorectal cancer (16), leukemias (21), and other cancers (24, 25, 26, 27). Here, HLA-C is linked to hepatocellular carcinoma.